About: Plasmapheresis and Intravenous Immunoglobulin in the Treatment and Prevention of Antibody Mediated Rejection

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Plasmapheresis and Intravenous Immunoglobulin in the Treatment and Prevention of Antibody Mediated Rejection Goto Sponge NotDistinct Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

Attributes	Values
rdf:type	skos:Concept http://linked.opendata.cz/ontology/domain/vavai/Vysledek
Description	In conclusion, the combination of plasmapheresis and intravenous immunoglobulin administration is considered to be a safe and effective treatment of early acute humoral rejection. A rituximab therapy should be better defined. In conclusion, the combination of plasmapheresis and intravenous immunoglobulin administration is considered to be a safe and effective treatment of early acute humoral rejection. A rituximab therapy should be better defined. (en)
Title	Plasmapheresis and Intravenous Immunoglobulin in the Treatment and Prevention of Antibody Mediated Rejection Plasmapheresis and Intravenous Immunoglobulin in the Treatment and Prevention of Antibody Mediated Rejection (en)
skos:prefLabel	Plasmapheresis and Intravenous Immunoglobulin in the Treatment and Prevention of Antibody Mediated Rejection Plasmapheresis and Intravenous Immunoglobulin in the Treatment and Prevention of Antibody Mediated Rejection (en)
skos:notation	RIV/00023001:_____/10:00002341!RIV11-MZ0-00023001
http://linked.open...avai/riv/aktivita	Z
http://linked.open...avai/riv/aktivity	Z(MZ0IKEM2005)
http://linked.open...iv/cisloPeriodika	4
http://linked.open...vai/riv/dodaniDat	2011
http://linked.open...aciTvurceVysledku	Honsová, Eva Bürgelová, Marcela Slavčev, Antonij Viklický, Ondřej Slatinská, Janka
http://linked.open.../riv/druhVysledku	J - Článek v odborném periodiku
http://linked.open...iv/duvernostUdaju	S - Úplné a pravdivé údaje nepodléhající ochraně podle zvláštních právních předpisů
http://linked.open...titaPredkladatele	Institut klinické a experimentální medicíny
http://linked.open...dnocenehoVysledku	279133
http://linked.open...ai/riv/idVysledku	RIV/00023001:_____/10:00002341
http://linked.open...riv/jazykVysledku	eng - angličtina
http://linked.open.../riv/klicovaSlova	acute antibody-mediated rejection; plasmapheresis; intravenous immunoglobulin; anti-CD20; graft survival; patient survival (en)
http://linked.open.../riv/klicoveSlovo	patient survival graft survival intravenous immunoglobulin acute antibody-mediated rejection anti-CD20 plasmapheresis
http://linked.open...odStatuVydavatele	DE - Spolková republika Německo
http://linked.open...ontrolniKodProRIV	[E2B53AA8376A]
http://linked.open...i/riv/nazevZdroje	Transplantationsmedizin
http://linked.open...in/vavai/riv/obor	FE
http://linked.open...ichTvurcuVysledku	5 (xsd:int)
http://linked.open...cetTvurcuVysledku	5 (xsd:int)
http://linked.open...UplatneniVysledku	2010
http://linked.open...v/svazekPeriodika	22
http://linked.open...iv/tvurceVysledku	Bürgelová, Marcela Honsová, Eva Viklický, Ondřej Slavčev, Antonij Slatinská, Janka
http://linked.open...n/vavai/riv/zamer	Výzkum kardiovaskulárních nemocí, diabetu a transplantace životně důležitých orgánů
issn	0946-9648
number of pages	5 (xsd:int)

Faceted Search & Find service v1.16.118 as of Jun 21 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 77 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software